Note: Descriptions are shown in the official language in which they were submitted.
1
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
Description
Title of Invention: MEDIUM COMPOSITION FOR PREPARING
BOTULINUM TOXIN
Technical Field
[1] The present invention relates to a medium composition for production of
botulinum
toxin and, more particularly, to a medium composition for culture of
Clostridium sp.
capable of producing botulinum toxin. The medium composition of the present
invention comprises a casein hydrolysate and at least one plant-derivedplant-
derived
peptone selected from the group consisting of a garden pea hydrolysate, a
cotton seed
hydrolysate and a wheat gluten hydrolysate.
[2]
Background Art
[31 A variety of Clostridium sp. that secrete neurotoxic toxins have been
discovered
since 1890s, and the characterization of toxins that are secreted from these
bacteria has
been made for the past 70 years (Schant, E. J. et al., Microbiol. Rev., 56:80,
1992).
[4] Neurotoxic toxins derived from the Clostridium sp., that is, botulinum
toxins, are
classified into seven serotypes (types A to G) depending on their serological
properties. Each of the toxins has a toxin protein having a size of about 150
kDa and
naturally comprises a complex of several non-toxic proteins bound thereto. A
medium
complex (300 kDa) is composed of a toxin protein and a non-toxic non-
hemagglutinin
protein, and a large complex (450 kDa) and a very large complex (900 kDa) are
composed of the medium-sized complex bound to hemagglutinin (Sugiyama, H.,
Microbiol. Rev., 44:419, 1980). Such non-toxic hemagglutinin proteins are
known to
function to protect the toxin from low pH and various proteases in the
intestines.
[51 The toxin is synthesized as a single polypeptide having a molecular
weight of about
150 kDa in cells, and then cleaved at a position of 1/3 starting from the N-
terminal end
by the action of intracellular protease or treatment with an artificial enzyme
such as
trypsin into two units: a light chain (L; molecular weight: 50 kDa) and a
heavy chain
(H; molecular weight: 100 kDa). The cleaved toxin has greatly increased
toxicity
compared to the single polypeptide. The two units are linked to each other by
a
disulfide bond and have different functions. The heavy chain binds to a
receptor of a
target cell (Park. M.K. et al., FEMS Microbiol. Lett., 72:243, 1990) and
functions to
interact with a biomembrane at low pH (pH 4) to form a channel (Mantecucco, C.
et
al., TIBS., 18:324, 1993), and the light chain has the pharmacological
activity of in-
terfering the secretion of neurotransmitters, when it is permeable to cells by
using
detergent or introduced by electroporation or etc (Poulain, B. et al., Proc.
Natl. Acad.
2
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
Sci. USA., 85:4090, 1988).
[6] The toxin inhibits the exocytosis of acetylcholine at the cholinergic
presynapse of a
neuromuscular junction to cause asthenia. It has been considered that even
treatment
with a very small amount of the toxin exhibits toxicity, suggesting that the
toxin has
any enzymatic activity (Simpson, L. L. et al., Ann. Rev. Phannacol. Toxicol.,
26:427,
1986).
171 According to a recent report, the toxin has metallopeptidase activity,
and its
substrates include composed of synaptobrevin, syntaxin, a synaptosomal
associated
protein of 25 kDa (SNAP25), etc., which are the unit proteins of an exocytosis
machinery complex. Each type of toxin uses one of the above-described three
proteins
as its substrate, and it is known that type B, D, F and G toxins cleave
synaptobrevin at
a specific site, type A and E toxins cleave SNAP25 at a specific site, and
type C
cleaves syntaxin at a specific site (Binz, T. et al., J. Biol. Chem.,
265:9153, 1994).
[81 Particularly, type A botulinum toxin is known to be soluble in a
dilute aqueous
solution at a pH of 4.0-6.8. It is known that a stable non-toxic protein is
separated from
neurotoxin at a pH of about 7 or higher, and as a result, the toxicity is
gradually lost.
Particularly, it is known that the toxicity decreases as pH and temperature
increase.
191 The botulinum toxin is fatal to the human body even in small amounts
and is easy to
produce in large amounts. Thus, it constitutes four major bio-terror weapons
together
with Bacillus anthracis, Yersinia pestis and smallpox virus. However, it was
found that,
when type A botulinum toxin is injected at a dose that does not systematically
affect
the human body, it can paralyze local muscle in the injected site. Based on
this charac-
teristic, type A botulinum toxin can be used in a wide range of applications,
including
wrinkle removing agents, agents for treating spastic hemiplegia and cerebral
palsy, etc.
Thus, the demand for type A botulinum toxin has increased, and studies on
methods of
producing botulinum toxin so as to satisfy the demand have been actively
conducted.
[10] A current typical commercial product is BOTOX (a purified neurotoxin
complex of
type A botulinum toxin) that is commercially available from Allergan, Inc.,
USA. A
100-unit vial of BOTOX is composed of about 5 ng of a purified neurotoxin
complex
of type A botulinum toxin, 0.5 mg of human serum albumin and 0.9 mg of sodium
chloride and is reconstituted using sterile saline without a preservative
(injection of
0.9% sodium chloride). Other commercial products include Dysport (a complex
of
Clostridium botulinum type A toxin and hemagglutinin, which has lactose and
human
serum albumin in a pharmaceutical composition comprising botulinum toxin and
is re-
constituted using 0.9% sodium chloride before use) that is commercially
available
from Ipsen Ltd., UK, MyoBloc (an injectable solution (a pH of about 5.6)
comprising
botulinum type B toxin, human serum albumin, sodium succinate and sodium
chloride)
that is commercially available from Solstice Neurosciences, Inc.
3
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[11] A medium for culture of Clostridium botulinum, which is generally used
in a method
for production of botulinum toxin as disclosed in Korean Patent No. 10-
1339349,
comprises animal components. Thus, if an animal abnormal prion known as an
agent
that causes transmissible spongiform encephalopathy is contained in the animal
components due to contamination, it poses problems in a process for producing
botulinum toxin.
[12] Transmissible spongiform encephalopathy (TSE) is known as a
neurodegenerative
disorder causing serious degeneration of neurons, and examples thereof
includes
bovine spongiform encephalopathy (BSE), Scrapie, Creutzfeldt-Jakob disease
(CJD),
Gerstmann-Straussler-Scheinker syndrome, Kuru, transmissible mink
encephalopathy,
chronic wasting disease, feline spongiform encephalopathy, etc., which affect
humans
and animals. It was reported that BSE crosses the species barrier and infects
even
humans.
[13] The agent that causes transmissible spongiform encephalopathy (TSE)
has charac-
teristics in that it has no immunogenicity and the incubation period is long.
From
histopathological analysis of BSE-affected bovine brain tissue, it can be seen
that
special spongiform vacuoles were formed in the brain due to damage to neurons
and
deposition of abnormal protein fibers.
[14] The cause of TSE is a proteinaceous infectious particle known as the
abnormal prion.
Unlike general viruses that require nucleic acid, the abnormal prion is an
infectious
particle composed of protein alone without containing nucleic acid. garding
TSE, it is
known that, when an abnormal prion (PrPsc) that is an infectious particle
binds to a
normal prion (PrPc), it is converted to a pathogenic prion which is then
accumulated in
the brain (Prusiner SB, Alzheimer Dis Assoc Disord., 3:52-78, 1989).
[15] Creutzfeldt-Jakob disease is a rare neurodegenerative disorder of
human trans-
missible spongiform encephalopathy (TSE) where the transmissible agent is
apparently
an abnormal isoform of a prion protein. An individual with Creutzfeldt-Jacob
disease
can deteriorate from apparent perfect health to akinetic mutism within six
months.
Thus, a potential risk may exist of acquiring a prion mediated disease, such
as
Creutzfeldt-Jacob disease, from the administration of a pharmaceutical
composition
which comprises a biologic, such as a botulinum toxin, obtained using animal-
derived
products. Thus, if a pharmaceutical composition is prepared by drug substance
produced using animal-derived components, it can subject the patient to a
potential risk
of receiving various pathogens or infectious agents.
[16] Under this technical background, the present inventors have found
that, when a
medium comprising transmissible spongiform encephalopathy(TSE)-free plant-
derived
peptone, mineral components and TSE-free casein hydrolysate (e.g., TSE-
certificated
casein hydrolysate) is used for culture of Clostridium botulinum in order to
prevent the
4
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
risk of developing the above-described prion-mediated disease, the risk of de-
velopment of the prion-mediated disease that can occur in a medium that is in
current
use (original medium) can be excluded, and the growth rate of Clostridium
botulinum
in the medium can be increased compared to that in the medium that is in
current use
and the plant-derived peptone-containing medium, thereby completing the
present
invention.
[17]
Disclosure of Invention
Technical Problem
[18] It is an object of the present invention to provide a medium
composition comprising
a plant-derived peptone having no risk of transmissible spongiform
encephalopathy
(TSE) infection and a casein hydrolysate having no risk of TSE infection, and
a
method for production of botulinum toxin, which improves the production of
botulinum toxin by culturing Clostridium botulinum in the medium composition.
[19]
Solution to Problem
[20] To achieve the above object, the present invention provides a medium
composition
for culture of Clostridium botulinum, the medium composition comprising: at
least one
plant-derived peptone selected from the group consisting of a garden pea
hydrolysate,
a cotton seed hydrolysate and a wheat gluten hydrolysate; and a casein
hydrolysate.
[21] The present invention also provides a method for producing botulinum
toxin,
comprising the steps of: (a) culturing Clostridium botulinum using the medium
com-
position to produce botulinum toxin; and (b) recovering the produced botulinum
toxin.
[22]
[23] Brief Description of The Drawings
[24] FIG. 1 shows the growth of Clostridium botulinum in a medium (APF
medium)
comprising plant-derived peptone.
[25] FIG. 2 shows the growth of Clostridium botulinum in a medium
comprising plant-
derived peptones, minerals, amino acids and vitamins.
[26] FIG. 3 shows the results of examining whether a precipitate is formed
after ster-
ilization of a medium comprising plant-derived peptones, minerals, amino acids
and
vitamins.
[27] FIG. 4 shows the results of examining whether a precipitate is formed
after ster-
ilization of a medium comprising plant-derived peptones and minerals.
[28] FIG. 5 shows the growth of Clostridium botulinum in media obtained by
additionally
adding vitamins, amino acids and "BD RechargeTM without Glucose and L-
Glutamine"
to media for culture of the bacterium, which contain plant-derived peptones
and
5
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
minerals.
[29] FIG. 6 shows the growth of Clostridium botulinum in media for culture
of the
bacterium, which contain various kinds of plant-derived peptones.
[30] FIG. 7 shows contour plots of FFD for mineral screening, and response
optimization.
FIG. 7a contour plot for high setting; FIG. 7b contour plot for middle
setting; FIG. 7c
contour plot for low setting; and FIG. 7d response optimization for maximum
OD.
[31] FIG. 8 shows contour plots of FFD for mineral screening, and response
optimization.
FIG. 8a contour plot for high setting; FIG. 8b contour plot for middle
setting; FIG. 8c
contour plot for low setting; and FIG. 8d response optimization for maximum
OD.
[32] FIG. 9 shows contour plots for plant peptone screening, and response
optimization.
FIG. 9a contour plot for middle setting; FIG. 9b contour plot for low setting;
and FIG.
9c response optimization for maximum OD.
[33] FIG. 10 shows the growth curve of Clostridium botulinum in the finally
selected APF
medium, and a change in toxin concentration.
[34] FIG. 11 shows contour plots for a culture medium at 24 hours after
inoculation of
Clostridium botulinum into a medium comprising plant-derived peptones to which
a
casein hydrolysate has been added. FIG. lla contour plot for lower setting;
and FIG.
1 lb contour plot for middle setting.
[35] FIG. 12 shows response optimization for a culture medium at 24 hours
after in-
oculation of Clostridium botulinum into a medium comprising plant-derived
peptone to
which a casein hydrolysate has been added.
[36] FIG. 13 shows contour plots of a CCF (central composite faced) design.
(A) plot of
statistical program; and (B) plot of statistical program.
[37] FIG. 14 shows contour plots (A) of a CCF (central composite faced)
design, and a
optimization plot (B).
[38] FIG. 15 is a set of graphs showing time-dependent OD values indicating
the growth
of Clostridium botulinum in a medium that is in current use, a medium
comprising
plant-derived peptones and a medium comprising plant-derived peptones and
casein
hydrolysate.
[39]
[40] Best Mode For Carrying Our The Invention
[41] In the present invention, an animal protein-free (APF) medium
composition showed
an increased growth rate of Clostridium botulinum compared to a medium that is
in
current use (original medium), but it was taken into account to add medium
components that further increase the growth rate of the bacterium and have no
risk of
infection with TSE or the like. Thus, a casein hydrolysate (e.g., a TSE-
certificated
casein hydrolysate), which has not been reported to cause TSE infection, was
added to
the APF medium, and the growth of the bacterium in the APF medium was
examined.
6
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
As a result, the APF medium showed an increased growth rate of the bacterium
compared to a medium that is in current use and a medium comprising plant-
derived
peptones alone. Thus, if the above medium is used, a high concentration of
botulinum
toxin can be produced by culturing a bacterium in a safe manner under TSE-free
conditions.
[42] As used herein, the term "medium that is in current use or original
medium" means a
medium comprising casein hydrolysate, yeast extract and thioglycollate medium,
which are animal-derived medium components. The term "APF medium (animal
protein-free medium)" means a medium that contains no animal-derived protein
and
that contains plant-derived peptones, minerals and glucose.
[43] In an example of the present invention, in order to produce botulinum
toxin by
culturing Clostridium botulinum under transmissible spongiform encephalopathy
(TSE)-free conditions, an APF medium comprising TSE-free plant-derived peptone
was prepared and compared with a medium that is in current use (containing an
animal
component). As a result, it could be seen that an optimal medium composition
for
culturing Clostridium botulinum is one comprising a plant-derived peptone, at
least
one mineral selected from the group consisting of KH2PO4, K2HPO4 and Na2HPO4,
and
a carbon source (e.g., glucose, and the optimal growth of the bacterium in
this medium
was found. As a result, as shown in Table 13, it was determined that the
optimal
contents of plant-derived peptones in the finally selected medium composition
for
culture of Clostridium botulinum are 5 g/L Hy-PeaTM 7404, 10 g/L UltraPepTM
Cotton
and 5 g/L HyPepTM 4601N, and the optimal contents of minerals in the medium
com-
position are 5.5 g/L K2HPO4 and 3g/L Na2HPO4.
[44] In another example of the present invention, the growth pattern of
Clostridium
botulinum in the finally selected APF medium comprising plant-derived peptones
and
minerals and the toxin concentration were measured. As a result, as shown in
Table 12
and FIG. 10, the OD value started to increase after 12 hours of culture of
Clostridium
botulinum, and at 24 hours of culture, the culture medium showed an 0D540õ,,
of
3.5465 and an 0D600õ,, of 3.0695. Then, the OD value decreased gradually, and
at 48
hours of culture, the culture medium showed an 0D540õ,, of 0.792 and an
0D600õ,, of
0.7224. The toxin concentration in the culture supernatant of Clostridium
botulinum
started to increase after 5 hours of culture and showed a final value of 31.41
,ug/ml.
When the toxin concentration was measured after rupturing the bacterium, the
toxin
started to be produced after 5 hours of culture, and the toxin concentration
continued to
increase, was maintained at a uniform level after 28 hours of culture, and
showed a
final value of 38.39 ,ug/ml.
[45] In another example of the present invention, the growth pattern of
Clostridium
botulinum in a medium containing plant-derived peptones and casein hydrolysate
was
7
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
examined. As a result, as shown in Table 17 and FIG. 15, a medium that is in
current
use showed an increase in the growth rate after 24 hours of culture of
Clostridium
botulinum and showed the peak 0D540õ,, value of 3.384 at 39 hours of culture.
An APF
medium containing plant-derived peptones showed an increase in the growth rate
after
18 hours of culture and showed a peak 0D540õ,, value of 3.526 at 28 hours of
culture.
[46] In addition, a plant-derived peptone-containing APF medium + casein
hydrolysate
showed an increase in the growth rate after 18 hours of culture and showed a
peak OD
540nm value of 5.628 at 26 hours of culture. Thus, the 0D540,1,, value at 24
hours of
culture was compared, the medium that is in current use showed an 0D540,1,,
value of
1.2382, the plant-derived peptone-containing APF medium showed an 0D540,1,,
value of
2.8595, and the plant-derived peptone-containing APF medium + casein
hydrolysate
showed an 0D540,1,, value of 5.244. Thus, the OD value of the plant-derived
peptone-
containing APF medium + casein hydrolysate at 24 hours of culture was about
4.23
times higher than that of the medium that is in current use and about 1.83
times higher
than that of the plant-derived peptone-containing APF medium. And the peak OD
value of the plant-derived peptone-containing APF medium + casein hydrolysate
was
about 1.6 times higher than that of the plant-derived peptone-containing APF
medium.
[47] As shown in Table 18, it was determined that the optimal contents of
plant-derived
peptones in the finally selected medium composition for culture of Clostridium
botulinum, which contains a transmissible spongiform encephalopathy (TSE)-free
casein hydrolysate, are 5 g/L Hy-PeaTM 7404, 10 g/L UltraPepTM Cotton and 5
g/L
HyPepTM 4601N, and the optimal contents of minerals in the medium composition
are
5.5 g/L K2HPO4 and 3 g/L Na2HPO4, and the contents of the casein hydrolysates
are 20
g/L N-Z-Amine A and 11 g/L N-Z-Case TT.
[48] Based on this, in one aspect, the present invention is directed to a
medium com-
position for culture of Clostridium botulinum, the medium composition
comprising: at
least one plant-derived peptone selected from the group consisting of a garden
pea hy-
drolysate, a cotton seed hydrolysate and a wheat gluten hydrolysate; and a
casein hy-
drolysate.
[49] As used herein, the term "plant-derived peptone" means a peptone
extracted from
garden pea, cotton seed or wheat gluten. Preferably, the plant-derived peptone
may be
commercially available Hy-PeaTM 7404, UltraPepTM Cotton, HyPepTM 7504 or
HyPepTM 4601N, but is not limited thereto. The term "casein hydrolysate" means
a
component extracted from milk. Preferably, the casein hydrolysate may be a
casein hy-
drolysate containing about 85.5-94.5 wt% of peptides having a molecular weight
of
500 Da or less, or a casein hydrolysate containing about 63.56-70.25 wt% of
peptides
having a molecular weight of 500 Da or less. More preferably, the casein
hydrolysate
may be commercially available N-Z-Amine A or N-Z-Case TT, but is not limited
8
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
thereto.
[501 As used herein, the term "plant-derived peptone" or "plant-derived
hydrolysate"
means a product obtained by degrading a protein isolated from a plant. For
example,
the garden pea peptone (garden pea hydrolysate) means a product obtained by
degrading a total protein isolated from garden pea. In addition, the term
"casein hy-
drolysate" means a product obtained by degrading casein protein.
[511 Degradation of the plant-derived protein or the casein protein is
preferably performed
by partial digestion. Degradation of the protein is preferably performed by
acid
treatment, base treatment, enzyme treatment, high-pressure treatment, heat
treatment or
physical treatment. More preferably, the plant-derived peptone or the casein
hy-
drolysate may be one obtained by enzyme treatment. The physical treatment is,
for
example, grinding.
[521 The plant-derived peptone or casein hydrolysate that is used in the
present invention
is a partial degradation product of protein, is a mixture comprising not only
amino
acids that are single molecules, but also peptides composed of several to
several tens of
amino acids, and intact protein molecules.
[531 In the present invention, the content of the plant-derived peptone in
the medium com-
position may be 0.1-10 w/v% (1-100 g/L), preferably 0.2-5 w/v% (2-50 g/L),
more
preferably 0.5-2 w/v% (5-20 g/L).
[541 In the present invention, the medium composition contains all the
garden pea hy-
drolysate, the cotton seed hydrolysate and the wheat gluten hydrolysate, and
the
content ratio of the garden pea hydrolysate, the cotton seed hydrolysate and
the wheat
gluten hydrolysate in the medium composition may be 1:0.24-43.62:0.01-50.57 by
weight, preferably 1:0.68-14.46:0.09-9.87 by weight, more preferably 1:1.6-
2.4:0.6-1.4
by weight.
[551 In the present invention, the content of the casein hydrolysate in the
medium com-
position may be 0.22-15.5 w/v% (2.2-155g/L), preferably 0.44-7.75 w/v% (4.4-
77.5 g/
L), more preferably 1.1-3.1 w/v% (11-31 g/L).
[561 In the present invention, the casein hydrolysate may be a hydrolysate
containing
about 85.5-94.5 wt% of peptides having a molecular weight of 500 Da or less
and/or a
hydrolysate containing about 63.56-70.25 wt% of peptides having a molecular
weight
of 500 Da or less.
[571 In the present invention, the casein hydrolysate comprises both a
hydrolysate
containing about 85.5-94.5 wt% of peptides having a molecular weight of 500 Da
or
less and a hydrolysate containing about 63.56-70.25 wt% of peptides having a
molecular weight of 500 Da or less, and the content ratio of the hydrolysate
containing
about 85.5-94.5 wt% of peptides having a molecular weight of 500 Da or less
and the
hydrolysate containing about 63.56-70.25 wt% of peptides having a molecular
weight
9
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
of 500 Da or less may be 0.01-40:0.01-22 by weight, preferably 10-30:5.5-16.5
by
weight, more preferably 16-24:8.8-13.2 by weight.
[58] In the present invention, the medium composition for culture of
Clostridium
botulinum may further contains a carbon source and at least one mineral
selected from
the group consisting of K2HPO4 (dipotassium phosphate), Na2HPO4 (disodium
phosphate) and KH2PO4 (monopotassium phosphate).
[59] Herein, examples of the carbon source include, but are not limited to,
monosac-
charides (e.g., glucose, fructose, etc.), disaccharides (e.g., maltose,
sucrose, etc.),
oligosaccharides, polysaccharides (e.g., dextrin, cyclodextrin, starch, etc.),
sugar
alcohols (e.g., xylitol, sorbitol, erythritol, etc.).
[60] In the present invention, the content of the mineral in the medium
composition may
be 0.05-3.5 w/v%(0.5-35 g/L), preferably 0.1-1.75 w/v% (1-17.5 g/L), and more
preferably 0.25-0.7 w/v% (2.5-7 g/L).
[61] In another aspect, the present invention is directed to a method for
producing
botulinum toxin, comprising the steps of: (a) culturing Clostridium botulinum
using the
above-described medium composition to produce botulinum toxin; and (b)
recovering
the produced botulinum toxin.
[62] In the present invention, the culturing may be performed under
anaerobic conditions,
and the botulinum toxin may be selected from the group consisting of botulinum
toxin
types A, B, C, D, E, F and G.
[63]
[64] Examples
[65] Hereinafter, the present invention will be described in further detail
with reference to
examples. It will be obvious to a person having ordinary skill in the art that
these
examples are illustrative purposes only and are not to be construed to limit
the scope of
the present invention. Thus, the substantial scope of the present invention
will be
defined by the appended claims and equivalents thereof.
[66]
[67] Example 1: Culture of Clostridium botulinum in Plant-derived Peptone
Medium
[68] 1-1: Composition of a Medium Currently Used in Culture
[69] The reagents and medium components used in the present invention were
purchased
from Sigma (USA), Kerry Inc. (USA), BD Biosciences (USA), Gibco Life Tech-
nologies (USA), and Quest (USA).
[70] A medium that is in current use having a composition comprising 2%
casein hy-
drolysate (20 g/L), 1% yeast extract (10 g/L), 1% glucose (10 g/L) and 0.5%
thio-
glycollate medium (5 g/L) was used for the seed culture and main culture of
Clostridium botulinum to produce botulinum toxin. 5g of the thioglycollate
medium
per liter of the medium that is in current use is composed of 2.52 g of an
enzymatic
10
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
digest of casein, 0.84 g of yeast extract, 0.925 g of dextrose, 0.085 g of
sodium thio-
glycollate, 0.42 g of NaC1, 0.085 g of L-cysteine, 0.00014 g of Resazurin and
0.125 g
of bacteriological agar.
[71]
[72] 1-2: Composition of APF Medium Used in Culture
[73] A negative control medium was prepared by removing casein hydrolysate,
yeast
extract and thioglycollate medium from the medium that is in current use
(original
medium) for culture of Clostridium botulinum, and an animal protein-free (APF)
medium was prepared by adding four plant-derived peptone candidates (Hy-PeaTM
7404, UltraPepTM Cotton, HyPepTM 7504, and HyPepTM 4601N) to the negative
control
medium (Table 1).
[74]
[75] Table 1 shows the components of the plant-derived peptone-containing
APF medium
for culture of Clostridium botulinum in comparison with the medium that is in
current
use.
[76]
[77] [Table 11
medium that is Negative
Components of Medium Conc. (g/L)
in current use APF
Medium
Control
Glucose 10 10 10 10
Sodium Chloride (NaC1) 0.42 0.42 0.42 0.42
Casein hydrolysate /0 20
Yea st extract 10 10
Thioglycollate medium 5 5
=
Hy-PeaT51 7404 /0
lIJIraPepTM Cotton 10 10
HyPepTm 7504 10 10
HYPepTM 460 IN 10 10
[781
[79] 1-3: Seed Culture of Clostridium botulinum
[80] 20 [11 of Clostridium botulinum (the Korean Centers for Disease
Control and
Prevention Accession No.: 4-029-CBB-IS-001) was inoculated into a culture tube
containing 10 ml of a sterile medium having each of the compositions described
in
Examples 1-1 and 1-2 and was subjected to primary seed culture (stationary
culture) at
35 C for 22-30 hours under anaerobic conditions. When the growth of the
bacterium in
the primary seed culture was confirmed, 8 ml of the primary seed culture was
in-
oculated into a 1-liter culture bottle containing 800 ml of a sterile medium
having the
same medium composition and was subjected to secondary seed culture
(stationary
culture) at 35 C for 8-15 hours under anaerobic conditions.
11
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[81]
[82] 1-4 : Main Culture of Clostridium botulinum
[83] In order to produce a botulinum toxin by culturing Clostridium
botulinum, the main
culture of the bacterium was performed. Specifically, 9.3 L of a medium having
each
of the compositions described in Examples 1-1 and 1-2 was prepared and placed
in a
10-liter incubator, followed by sterilization of the medium. Nitrogen was
supplied to
make anaerobic conditions, and the growth of the bacterium was performed at a
tem-
perature of 35 C and an agitation speed of 50 rpm.
[84] The secondary seed culture in the 1-liter culture bottle in Example 1-
3 was inoculated
into a 10-liter incubator through an inoculation line connected to the
inoculation port
of the 10-liter incubator. Clostridium botulinum in the 10-liter incubator was
cultured
under the conditions of 35 C and 50 rpm and the set culture conditions were
monitored
and recorded. When the bacterium was cultured for 100 hours or more, the main
culture was terminated.
[85] The growth of Clostridium botulinum in the animal protein-free (APF)
medium
prepared by adding four types of plant-derived peptone candidates (Hy-PeaTM
7404,
UltraPepTM Cotton, HyPepTM 7504, and HyPepTM 4601N) to the negative control
medium was compared with that of the bacterium in the negative control medium
prepared by removing casein hydrolysate, yeast extract and thioglycollate
medium
from the medium that is in current use (original medium) (Table 1).
[86] As a result, as shown in Table 1 and FIG. 1, Clostridium botulinum did
not grow in
the negative control medium, but started to grow in the original medium
(medium that
is in current use) at 24 hours after inoculation of the bacterium and started
to grow in
the plant-derived peptone-containing medium at 30 hours after inoculation of
the
bacterium.
[87]
[88] Example 2: Culture of Clostridium botulinum in Medium Containing Plant-
derived
Peptone, Mineral, Amino Acid and Vitamin
[89] Because the growth of Clostridium botulinum in the medium prepared by
adding four
plant-derived peptones in Example 1 was slower than that in the original
medium,
solutions thereto were provided as follows.
[90] 1) To examine the effect of thioglycollate functioning to make
anaerobic conditions,
thioglycollate was removed from the original medium (medium that is in current
use),
and a change in the growth rate of the bacterium in the thioglycollate-free
medium was
analyzed.
[91] 2) Because the slower growth rate could be because of the lack of the
nitrogen
source, the peptone concentration in the medium used for culture of the
bacterium was
increased two times.
12
CA 02968044 2017-05-16
WO 2016/175566
PCT/KR2016/004431
[92] 3) The growth of Clostridium botulinum in a medium obtained by adding
mineral,
amino acid and vitamin to the plant-derived peptone-containing medium was
compared
with the growth of Clostridium botulinum in an APF medium disclosed in U.S.
Patent
No. 8,012,716 (Allergan) (Table 2).
[93]
[94] Table 2 shows the components of the medium for culture of Clostridium
botulinum,
which contains plant-derived peptones, minerals, amino acids and vitamins.
[95]
[96] [Table 21
_
1 APF
2 3 4
medium (APE
Medium of
that is (APF (APF (APF
Components of Medium g/L Medium Allerg,an
in current Meditmi Medium Medium
Candidat
Company
use Candidate) Candidate) Candidate)
e)
,
'
Glucose 10 10 _ 10 10 10 10 15
Sodium Chloride (NaCh 0.42 0.42 0.42 0.42 0.42 0.42 -
Casein hydroly sate 20 20 _ 20 - - -
Yeast exIract 10 10 10 .- - - 12
Thioglycollate medium 5 5 - - -
-
jJy4TM 7404 20 - - 20 40 20 -
UltraPepTm Cotton 10 - - 10 20 10 - .
HyPeem 7504 10 - -10 20 10 -
. ,
Eiger" 4601N 10 - - 10 20 10 -
Isal2PO4 7 - - 7 -
=
K2HPO4 5.5 - - - - 5.5 -
Na,11PO4 5 - - - - 5 -
MO'711
0420 10 _ - - - 10 -
. . .
Vitamin Kit 100X - . - - 1X -
Amino acid mixture 50X - - . - - 1X -
Soy peptone 32.5 .. - - - - 32.5
[97]
[98] As a result, as shown in Table 2 and FIG. 2, when the bacterium was
cultured in the
medium that is in current use without thioglycollate, the growth rate of the
bacterium
in the medium was slower than that in the thioglycollate-containing medium, in-
dicating that thioglycollate influences the growth rate of the bacterium. When
the
peptone concentration in the medium was increased two times, the bacterium did
not
grow in the medium. When in the case in which mineral components, amino acids
and
vitamins were added to the peptone-containing medium, the growth rate of the
bacterium was similar to that in the medium that is in current use, but a
precipitate was
formed after sterilization of the medium. In addition, it was seen that the
growth rate of
the bacterium in the Allergan's APF medium was similar to that in the medium
that is
13
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
in current use.
[99]
[100] Example 3: Production of Precipitate by Sterilization of Medium
Containing Plant-
derived Peptones, Minerals, Amino Acid and Vitamin
[101] In Example 2, it was observed that the growth rate of Clostridium
botulinum in the
medium containing plant-derived peptones, minerals, amino acids and vitamins,
among
the APF medium candidates 2 to 4 shown in Table 2, was similar that in the
medium
that is in current use. However, formation of a precipitate appeared after
sterilization of
the medium, and thus the cause thereof was examined (Table 3).
[102]
[103] Table 3 shows the components of a medium for culture of Clostridium
botulinum,
which was used in sterilization and contains plant-derived peptones, minerals,
amino
acids and vitamins.
[104]
[105] [Table 3]
1 2 3
medium 4
that is (APF (APF (APF
Components of Medium g/L (APF Medium
in current Medium Meditun Medium
Candidate)
use Candidate) Candidate) Candidate)
Glucose 10 10 10 10 10 10
Sodium Chloride (NaC I) 0.5 0.5 0.5 0.5 0.5 0.5
Casein hy droly sate 20 20
- - _ -
Yeast extract 10 10- - - -
Thioglycollate medium 5 5- - - -
Hy-PeaTM 7404 20- 20 10 20 20
UltraPeem Cotton 10- 10 10 10 10
IlyPepTM 7504 10 10 10 10 10
HyPepTm 4601N 10- 10 10 10 10
ICH, PO, 7_ - 7 7 -
K,HPO4 5.5- - 5.5 5.5 -
Na,11PO4 5- - 5 5 -
MgSO4 711,0 10- - 10 10 -
IX (Adding after
Vitamin Kit 100X- - IX IX
Sterilization)
IX (Adding after
Amino acid mixture 50 X- IX - IX
Sterilization)
11061
14
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[107] As a result, as shown in Table 3 and FIG. 3, only in the case in
which minerals were
added to the plant-derived peptone-containing medium, a precipitate was formed
after
sterilization of the medium, indicating that the main cause of formation of
the pre-
cipitate was the minerals. This is believed to be because the mineral
components in-
teracted with one another under the conditions of high temperature and high
pressure
during sterilization of the medium.
[108]
[109] Example 4: Formation of Precipitate by Sterilization of Medium
Containing Plant-
derived Peptones and Minerals
[110] In order to identify the mineral components involved in the formation
of precipitate
caused by sterilization as confirmed in Example 3, various combinations of
different
components were added to media, followed by sterilization (Table 4).
[111]
[112] Table 4 shows the components of media for culture of Clostridium
botulinum, which
contain plant-derived peptones and minerals, and the results of sterilization
of the
media.
[113]
[114] [Table 4]
1 2
3 4 5 6 7 8 9 10
11 12
mediu (APF (APF
(APF (APF (APF (APF (APF (APF (APF (APF (APF (APF
'
Components of m that Mediu Mediu Mediu Mediu Mediu Mediu Mediu
Nlediu Mediu Mediu
is
Medium m m in m m in in 1111 111 in m
m
in
Candid Candid Candi Candi Candid Candi Candid Canill Candi Candi
current Candid Candhl
ate) ate) date) date) ate) date) ate) date) date) date)
US e ate) ate)
Glucose 10 10 10 10 10 10 10 10 10 10 10
10 10 10
Sodium Chloride
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.5 0.5 0.5 0.5 0.5
(Na
Casein hydrolysate 20 20 - -
Yeast extract 10 10 _ _ _ _ _ _ _
_
_ .
Thloglycollate
5
medium
Hy-Pear" 7404 20 20 20 20 20 20 20 20 20
20 20 20 20
UltraPepTm Cotton 10 - , 10 , 10 10 10 , 10 10 10
10 , 10 , 10 10 10
HyPepTm 7504 10 10 10 10 10 10 10 10 10
10 10 10 10
HyPerd 4601N 10 10 10 10 10 10 10 10 10 10 10
10 10
ICH,PC11, 7 7 7 7 7 - 7 7 - 10
5.5 - - 5.5 5.5 - 5.5 5.5 - -
5.5 5.5 5.5 -
Na,HPO4 5 - - - - - 5 - 5
MgS04711,0 10 - 10 10 10 10 - 10 10 -
- 10 -
_
precipitation,
x o o o o x o x x xo
x
aggregation
[115]
[116] As a result, as shown in Table 4 and FIG. 4, among the media
containing plant-
derived peptones and minerals, the medium containing Mg504-7H20 and K2HPO4 and
15
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
the medium containing MgSO4-7H20 and Na2HPO4 formed a precipitate after ster-
ilization.
[117]
[118] Example 5: Culture of Clostridium botulinum under Conditions in which
no Pre-
cipitate is formed in APF Medium
[119] An experiment was performed to determine whether culture of
Clostridium
botulinum is possible when vitamin and amino acid are additionally added to
the APF
medium of Example 4containing plant-derived peptones and minerals. In
addition, an
experiment was performed to examine whether culture of the bacterium is
possible in a
medium which is free of plant-derived peptone and mineral and contains
vitamins,
amino acids and/or "BD RechargeTM without Glucose and L-Glutamine" (Cat No.
670002, BD Bioscience) (a yeast extract-based medium component free of glucose
and
L-glutamine) (Table 5).
[120]
[121] Table 5 shows the components of media obtained by additionally adding
vitamins,
amino acids and "BD RechargeTM without Glucose and L-Glutamine" to the medium
for culture of Clostridium botulinum, which contains plant-derived peptones
and
minerals, and the growth rates of the bacterium in the media.
[122]
16
CA 02968044 2017-05-16
WO 2016/175566
PCTXR2016/004431
[123] [Table 5]
medi 1 2 3 4 5 6 7 8 9 10
11 12
um (APF (APF (APF (APF (APF (APF (APF (APF (APF (APF (APF (APF
Components of that Mediu Mediu Mediu Mediu Mediu Mediu Mediu Mediu
Nlediu Mediu Mediu Mediu
g/L is
Medium
in m m m m m m m m m m m m
curre Candid Candid Candid Candid Candid Candid Candid Candid Candid Candid
Candid Candid
tit use ate) ate) ate) ate) ate) ate) ate)
ate) ate) ate) ate) ate)
Glucose 10 , 10 10 _ 10 10 , 10 . 10 10 , 10 . 10
10 , 10 , 10 , 10
Sodium Chloride
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.5 0.5 0.5 0.5 0 5
(NaC1)
Casein
20 20 - - - - - - - - - - -
-
hydrolysate . .
- - - - - - .
-
= .
least extract 10 . 10 , - - _ _ . _ _ _ _
. _ _ _
, .
, . ,
Thioglycollate
. - - ' " . - _
5 . - . .
medium
. . .
Sodium
1 1 -
thiogiycollate
Hy-PeaT" 7404 20 . - . 20 , 20 20 , 20 . 20 _ 20 _ 20 .
20 20 , 20 , - , -
unraPepTsi
- 10 10 10 10 10 10 10 10 10 10 -
Cotton
HyPepT" 7504 , 10 , - , 10 10 10 , 10 . 10 10
, 10 10 10 , 10 - -
HyPepT" 4601N 10 . - 10 . 10 10 . 10 . 10 10 .
10 , 10 10 10
ICH,P0., - , - , - - - , - , - - , - , - - , - , -
K,HPO,
Na,HPO., , 5 . - . - . 5
MgSO4 7H20 10 - - 10 - . -
Vitamin Kit 100X IX IX IX IX IX IX - - .
IX - IX
Amino acid
lx IX IX IX IX IX - ix - ix
- - -
mixture 50 X ,
w/o Glucose and
45.42 -- - - - - - - 45.42 - 45
42 45.42 45.42
L-glutamine . .
Growth , x o x o , o o x x x, x x
o
,
Growin Grovrin Groin Groin
Cronin
Details gin gin gin gin
gin
24hrs 24hrs 24hrs 24hrs
48hr
[124]
[125] As a result, as shown in Table 5 and FIG. 5, only in the case in
which the medium
contained plant-derived peptones and a combination of two or more minerals of
KH2
PO4, K2HPO4 and Na2HPO4 and further contained vitamin and amino acid,
Clostridium
botulinum grew within 24 hours after inoculation of the bacterium. In
addition, in the
case in which the medium was free of plant-derived peptone and mineral and
contained
vitamins, amino acids and "BD RechargeTM without Glucose and L-Glutamine", the
bacterium grew within 48 hours after inoculation of the bacterium. In
conclusion, the
most suitable medium composition for culture of Clostridium botulinum
comprises
plant-derived peptones, KH2PO4, K2HPO4, Na2HPO4, amino acids and vitamins.
[126]
[127] Example 6: Culture of Clostridium botulinum in Media Containing
Different Plant-
17
CA 02 96 8044 2 0 17-05-16
WO 2016/175566
PCTXR2016/004431
derived Peptones
[128] An experiment was performed to examine whether culture of Clostridium
botulinum
is possible when different combinations of plant-derived peptones are added to
the
APF medium of Example 5.
[129]
[130] Table 6 shows the components of media for culture of Clostridium
botulinum, which
contain different plant-derived peptones, and the results of examining whether
the
bacterium grew in the media.
[131]
[132] [Table 6]
6 7 13
met 1 2 3 4 8 9 10 11 12
UM (APF (APF
(APF
(APF (APF (APF (APF (APF (APF (APF (APF (APF (APF
Components ot Medium that Mediu hledhl
Mediu
g/L is Medium Medium Medium Medium Medium Medium
Medium Medium Medium Medium
in Candida Candidat Candida
Canihriat Candida m m Candida Candidat Candidat Candida Candid m
CUITC Candid Candid
Candid
te) e) te) e) te) te) e) e) te) te)
nt use ate) ate)
ate)
Glucose 10 10 10 10 10 10 10 10 10 10
10 10 10 10 10
SodiumCbloride (NaCh 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.5 0.5 0.5 0.5 0.5 0.5 0.5
Caseinhydrolymte 20 20 - - - - - - - - - .
Yeastextract 10 10 - - - - - -
Thioglycollatemedium _ 5 _ 5 _ - - _ - -
Sodium thloglycollate 0.1 - - - - - - -
0.1 -
Hy-Peen 7404 10 , - , 10 10 - - - - 10
10 10 - -
UlttaPern Cotton 10 , - , 10 - 10 - - - 10 10
-
HyPer97504 10 - 10 - - 10 - 10 - 10 - 10
- - -
HyPeri 4601N 10 - 10 - - - 10 10 10 - 10
7 - 7 7 7 7 7 7 7 7 77 7
-
KHPO 5.5 - 5.5 5.5 5.5 5.5 55 5.5 5.5
5.5 5.5 5.5 5.5 - 5.5
Na,HPO, 5 - 5 5 5 5 5 5 5 5 5 5
5 . - 5
01080,7H20 10 - - - - -
Vitamin Kit 100X - IX IX IX IX IX IX IX IX
IX IX IX IX
Arninoacid mixture 50 X - - IX IX IX IX IX IX IX
IX IX IX IX IX
w/o Glucose and
45.42 -- - - - 45.42
45.42
1-glutamine
Growth o o o o o oo o o
[133]
[134] As a result, as shown in Table 6 and FIG. 6, even when only or two of
the four plant-
derived peptones were added to the medium, culture of Clostridium botulinum
was
possible.
[135] Taking the results of Examples 5 and 6 into account, it could be seen
that at least one
plant-derived peptone should be contained in the medium and that the plant-
derived
peptone cannot be substituted with "BD RechargeTm without Glucose and L-
Glutamine" (Cat No. 670002, BD Bioscience) (a yeast extract-based medium
component free of glucose and L-glutamine).
[136]
[137] Example 7: Experiment for Selection of Two of Three Minerals
Contained in
Medium
18
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[138] In Examples 1 to 7, it was determined that the APF medium composition
used for
culture of Clostridium botulinum comprises glucose, sodium chloride (NaC1),
four
plant-derived peptones, three minerals, amino acids, and vitamins. Among these
medium components, medium components having no significant effect on the
growth
of the bacterium were removed to reduce the number of the medium components.
Thus, it was judged that amino acids and vitamins have no significant effect
on the
growth of Clostridium botulinum, and under this judgment, amino acids and
vitamins
were removed from the medium components. In addition, in order to select two
of
three minerals, the bacterium was cultured using the medium compositions shown
in
Table 7, and the OD (540 nm and 600 nm) values at 24 hours and 48 hours after
in-
oculation of the bacterium were measured and compared.
[139]
[140] Table 7 shows the compositions of media resulting from the first-
stage selection of
minerals and the growth of Clostridium botulinum in the media.
[141]
[142] [Table 7]
medi 1 2 3 4 5 6 7 8 9 10 11
um
(APF (APF (APF (APF (APF (APF (APF (APF (APF (APF (APF
Components of that
g/L is
Mediu Nlediu Mediu Mediu Mediu Mediu Mediu Mediu Mediu Mediu Mediu
Medium
in 111111T11
CUITe
Candid Candid Candid Candid Candid Candid Candid Candid Candid Candid Candid
nt use
, ate) ate) ate) ate) ate) ate) ate)
ate) ate) ate) ate)
Glucose 10 10 10 10 10 10 10 10 10 10 10
10 10
Sodium Chloride
05 05 05 05 05 05 05 05 05 05
05 O. 05
(NaCh
Casein hydrolysate 20 20 -
Yeast extract 10 10 , -
Thioglycollate
5
medium
Hy-PeaTM 7404 10 - 10 10 10 10 10 10 10 10
10 10 10
IlltraPetirm Cotton 10 - 10 10 10 , 10 10 , 10
10 10 10 10 , 10
HyPer. 7504 10 - 10 10 10 10 10 10 10 10
10 10 10
HyPepTm 4601N 10 - 10 10 10 10 10 10 10 10
10 10 10
=
K.H,P0,
K,HPO, - 5 5 5 5 - - 5.5 5 5 -5 2 -5 2 -
5
Na,HPO4 5 5 5 5 5 2 5 2 5 2 5
540nm 0.942 -0.017 -0.024 4.396 3.226 4.218
3.214 4.964 3.991 3.951 3.938 3.594
Culture 24hr OD
600nm 0.780 -0.016 -0.020 3.832 2.691 3.593
2.680 4.304 3.351 3.341 3.335 3.036
540nm 2.459 -0.014 -0.019 4.716 5.220 3.502 5.460 2.056 2.603 5.726 5.682
5.434
Culture 48hr OD
600nm 2.057 -0.015 -0.018 3.852 4.288 2.989 4.480 1.587 2.020 4.688 4.647
4.459
[143]
[144] As a result, as shown in Table 7, at 24 hours of inoculation of the
bacterium, the
medium that is in current use showed an OD(540nm) value of 0.942, and the APF
medium containing K2HPO4 and Na2HPO4 showed the highest OD(540nm) value of
4.964 among the APF media. In addition, at 48 hours after inoculation of the
19
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
bacterium, the APF medium containing KH2PO4 and Na2HPO4 showed the highest
OD value and active bacterial growth.
[145] Meanwhile, as shown in FIG. 7, contour plots of K2HPO4 and Na2HPO4
having high
main effects were drawn. As a result, as the concentrations of K2HPO4 and
Na2HPO4
increased, the OD value increased. And Clostridium botulinum showed the
highest
growth when minerals were added to the medium at the concentrations of KH2PO4=
0
g/L, K2HPO4= 5.5 g/L, and Na2HPO4= 5 g/L.
[146] Meanwhile, in order to confirm the results of bacterial culture
according to more
precise addition of minerals, a second-stage experiment was performed using
response
surface methodology. Because the medium composition cannot have a negative
value,
the experiment was planned using a CCF (central composite faced) design and
performed by culturing the bacterium in the medium compositions shown in Table
8.
Then, the experimental results were combined with the results of the
previously
performed FFD and subjected to statistical analysis.
[147]
[148] Table 8 shows the compositions of media obtained by the second-stage
selection of
minerals and the growth of Clostridium botulinum in the media.
[149]
[150] [Table 81
medi
2 3 4 5 6 7
1 8 9 UM
(APF (APF (APF (APF (APF (APF that
(APE (APE (APF
Components of Medium g/L Mediu Mediu Mediu Mediu
Mediu Mediu is
Medium Medium Medium in
in m m m m m
Candida cams& candida
curre
Candid Candid Candid Candid Candid Candid nt use
te) te) te)
ate) ate) ate) ate) ate) ate)
Glucose 10 10 . 10 10 10 , 10 . 10 . 10 . 10 10 .
10
. Sodium Chloride (NaCh 0.5 0.5 0.5 0.5 .. 0.5 .. 0.5
0.5 . 0.5 . 0.5 .. 0.5 . -
Casein hydrolysate 20 - - - 20
Yeast extract 10 - _ - -
10
Thloglycollate medium 5 - - 5
Hy-Pealm 7404 10 10 10 10 10 10 10 10 10
10 -
UltraPeptm Cotton 10 10 10 10 10 10 10 10 .... 10
10 -
113TepTAI 7504 10 10 10 10 10 10 10 10 10
10 -
HyPepTm 4601N 10 10 10 10 10 10 10 10 10 10
7 . - 7 3.5 3.5 _ 3.5 3.5 3.5 _
3.5 . 3:5 -
K2HPO4 5.5 2.75 _ 2.75 - 5.5 2.75 2.75 2.75
2.75 2.75 -
Na1l-NO.1 5 2.5 2.5 2.5 2.5 - 5 2.5 2.5 , 2.5
-
540nm 4.408 3.587 2.233 4.639 1.778 4.332 3.904 1907 4.046 1.556
OD 24hr
600nm 3.836 3.086 1.896 4.068 1.503 3.777 3.366 3.38 3.505 1.307
540nm 5.021 5.760 4.359 3.594 4.529 4.054 6.492 5.621 5.473 3.622
OD 48hr
600nro 4.284 4.925 3.695 3.049 3.832 3.457 5.603 4.830 4.677 3.062
[151]
[152] Contour plots were drawn and used for comparison. As shown in FIG. 8,
the OD
value increased as the concentration of KH2PO4 decreased. When the optimal
20
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
conditions were compared, the results were different from the results of FFD
due to the
curvature effect, and the value of K2HPO4 was the same, but the value of
Na2HPO4
changed from 5g/L to 3.1313 g/L. Thus, it was confirmed that the optimal
mineral
conditions of the medium by statistical analysis are 5.5 g/L K2HPa4and 3 g/L
Na2HP0
4-
[153]
[154] Example 8: Experiment for Selection of Plant-derived Peptones
Contained in
Medium
[155] As shown in Tables 9 and 10, plant-derived peptones were combined
according to a
mixture design, and the growth of Clostridium botulinum in a medium containing
the
combined plant-derived peptones was examined.
[156]
[157] Table 9 shows the compositions of media obtained by the first-stage
selection of
plant-derived peptones and the growth of Clostridium botulinum using the
media.
[158]
[159] [Table 9]
medi
1 2 3 4 5 6 7 8 9 10
11 um
(APF (APF (APF (APF (APF (APF (APF (APF (APF (APF that
Componentsof (APF
g/L Mediu Mediu Mediu Mediu Mediu Mediu Mediu Mediu Mediu
Mediu is
Medium Medium in
en m m n In m m in m m
Ca ndida cUrre
Candid Candid Candid Candid Candid Candid Candid Candid Candid Candid nt
use
te)
ate) ate) ate) ate) , ate) ate) , ate)
ate) ate) ate) ,
Glucose , 10 . 10 10 19 10 . 10 10 10 . 10
10 10 10 10
Sodium Chloride
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
0.5 0.5 0.5
(NaC1)
Casein
20 20
hydroiysate
Yeast extract , 10 - 10
Thloglycollate
5
medium ,
Hy-PeaTM 7404 10 5 10 5 5 - - 6.667 6.667 - -
10
UltraPep 114
5 - 5 5 10 - 6.667 6.667 20 - 10
Cotton _
HvPepTM 7504 10 5 10 5 5 - 10 - 6.667 - 20
10
HyPerm 4601N 10 _ 5 - _ 5 _ 5 10 10 6.667 - - -
_ 10
klIPO, 5.5 5.5 , 5.5 _ 5.5 5.5 5.5 , 5.5 5.5 ,
5.5 5.5 5.5 5.5 ,
Na,11PO4 3 3 3 . 3 . 3 . 3 3 3 3 3 3 3 .
540mo 3.541 2.440 3.345 3.305 3.317 2.852 3.695 2.772 2.353 1.688 4.842
2.239
OD 24hr
600ttm 3.058 2.066 2.868 2.831 2.853 2.445 3.183 2.376 2.014 1.419 4.245
1.893
540nm 0.811 0.935 0.731 0.799 1.400 0.777 1.660 1.090 1.810 1.402 2.093
3.341
OD 48hr
600nm 0.714 0.795 0.647 0.694 1.199 0.680 1.403 0.929 1.548 1.210 1.764
2.812
[160]
[161] Table 10 shows the compositions of media obtained by the second-stage
selection of
plant-derived peptones and the growth of Clostridium botulinum using the
media.
21
CA 02 968044 2017-05-16
WO 2016/175566 PCTXR2016/004431
[162]
[163] [Table 101
1 2 medi
3 4 5 67 8 9 10 11 12 13
urn
(APE (APE
Components of TAPE (APE (APE (APE (APE (APE (APE (APE
(APE (APF (APF th,,t
g/L Mediu Medlu is
Medium Medium
MediUM Medium Medium Medium Medium Medium Medium Medium Medium Medium
UI m in
Candidat Candidat Candldat Candidat Candidat Candidat Can(iidat Candldat
Candldat Candldat Candidat curre
Candid Candid
e) e) e) e) e) e) e) e) e)
e) e) fit use
ate) 'te)
Glucose 10 10 10 10 10 10 10 10 10 10 10
10 10 10 10
Sodium Chloride
05 05 O5 05 05 05 05 05 05 05 05
05 05 0
(Nod)
20 Casein
_ _ 20
hydrolysate _
Yeast extract 10 - - -
10
Thioglycollate
medium
Hy-Peem 7404 10 5 5- 10 10 5 20 - 660- 10
10 10 -
IlltraPer.
5 5 10 666" 10 - S - 10 10 10 -
Cotton
HyPenrm 7504 10 5 5 10 066- - - 660- 10
10 10 -
HyPer. 4601N 10 5 5 - 006- _ 10 5 20 066- 10
10 10 -
H,Hpo, 5 5 5 5 5 5 5 5 5 5 5 55 5 5 5 5 5
5 5 5 5 5 5 5 5 5 _
Na,HPO, 3 , 3 , 3 3 3 3 3 3 3 3 3 3 3
3
540nm 1425 3640 2.349 2.581 1272 1.289 3,514 0.776 1.257
3.457 5.376 5.235 4.809 /208
OD 24hr
600nm, 2.969 3.159 /029 2.244 1.096 , 1096 3.032 0.649
1.098 2350 4.689 , 4.534 4246 1.863
540nm 0.769 0.836 1.633 0961 1.501 1.148 0.803 0.880 1.278
0.962 1.986 1394 2.810 1185
OD 48hr
600nrn 0675 0.732 1.420 9854 1.270 0.982 0.698 0.744 1.124
0.818 1.708 1.710 1.717 2.708
[164]
[165] As a result, as shown n FIG. 9, contour plots were drawn and used for
analysis. It
was determined that HyPepTM 7504 corresponding to the component C has the
lowest
effect on the growth of Clostridium botulinum. Based on this determination,
HyPepTM
7504 was excluded from medium components. In conclusion, it was determined
that
the composition of the finally selected plant-derived peptones that are
contained in the
medium comprises 5 g/L Hy-PeaTM 7404, 10 g/L UltraPepTM Cotton and 5 g/L
HyPepTM 4601N.
[166]
[167] Example 9: Culture of Clostridium botulinum in Medium Containing or
Not
Containing NaC1
[168] The medium compositions used in Examples 1 to 8 contained a small
amount (0.5 g/
L) of NaCl. In order to examine the growth of Clostridium botulinum according
to the
concentration change of NaC1, the content of NaC1 in the medium was adjusted
to a
range from 0 to 1 g/L, followed by culture of the bacterium in the medium.
[169]
[170] Table 11 shows the components of NaCl-containing media for culture of
Clostridium
botulinum and the growth of Clostridium botulinum in the media.
11711
22
CA 02968044 2017-05-16
WO 2016/175566
PCT/KR2016/004431
[172] [Table 111
1 2 3 4 5 6 7 8 9
Components of
gil, (APF (APF (APF (APF (APF (APF (APF
(APF (APF
Medium
Medium Medium Medium Medium Medium Medium Medium Medium Medium
Candidate) Candidate)Cantlidate)Candidate)
Canditbte)canditbte).Candidate),Candidate) Candidate)
Glucose 10 , 10 . 10 10 , 10 10 10
, 10 . 10 10
Sodium Chloride
0.5 - 0.5 0.5 0.5 1 1 1
(NaCl) _. .
'
_
. . .
Hy-PeaTm 7404 5 5 5 5 5 5 5 5 5 5
=
,
,
,
UltraPepTM
10 10 10 10 10 10 10 10 10
Cotton .
HyPepTm 4601N 5 5 5 5 5 5 5 5 5 5
K,HPO4 . 5.5 . 5.5 5.5 , 5.5 . 5.5 _
5.5 , 5.5 , 5.5 . 5.5 , 5.5 ,
Na211PO4 . 3 , 3 . 3 3 , 3 3 3 ,
3 , 3 3
540nm 2.166 2.154 2.151 2.148 2.115 2.120
2.145 2.147 2.140
'
OD 24hr
600nni 1.940 1.923 1.922 1.922 1.892 1.896
1.919 1.922 1.917
[173]
[174] As a result, as shown in FIG. 11, there was no difference in the
growth of the
bacterium whether the medium contained NaC1 or not. Thus, NaC1 was excluded
from
the final APF medium components.
[175]
[176] Example 10: Measurement of Growth Pattern of Clostridium botulinum in
Finally
Selected APF Medium and Toxin Concentration
[177] Clostridium botulinum was inoculated into the finally selected
Clostridium
botulinum culture medium (10g/L glucose, 5g/L Hy-PeaTM 7404, 10g/L UltraPepTM
Cotton, 5g/L HyPepTM 4601N, 5.5g/L K2HPO4, and 3g/L Na2HPO4) determined based
on the results of Examples 1 to 9, and then the growth pattern of the
bacterium and the
toxin concentration were measured.
[178]
[179] Table 12 shows the time-dependent OD value and the toxin
concentration of
Clostridium botulinum grown in the finally selected APF medium.
[180]
23
CA 02968044 2017-05-16
WO 2016/175566
PCT/KR2016/004431
[181] [Table 121
OD
Total Toxin Conc.
Toxin Conc. in
Time of Culture (hr) after
rupturing
Supernatant (ug/m1)
540nm 600nm
strain (ug/ml)
0 0 0 0
6 0.0953 0.0393 0.00 0.00
9 0.0648 0.0525 0.00 0.00
12 0.5003 0.4411 0.00 0.00
14 1.1328 0.9958 2.18 2.04
16 1.6252 , 1.4484 4.64 10.22
18 2.3435 2.0215 6.77 18.15
20 2.777 2.4015 8.47 29.26
22 3.3485 2.896 9.46 31.86
24 3.5465 , 3.0695 31.73
28 3.452 2.982 37.31
36 2.5955 2.242 21.20 38.00
48 0.792 0.7224 31.41 38.39
[182]
[183] As a result, as shown in Table 12 and FIG. 10, the OD value started
to increase after
12 hours of culture of Clostridium botulinum, and at 24 hours of culture, the
culture
medium showed an 0D540,1,, of 3.5465 and an 0D600,1,, of 3.0695. Then, the OD
value
decreased gradually, and at 48 hours of culture, the culture medium showed an
0D540.
of 0.792 and an 0D600n. of 0.7224. The toxin concentration in the supernatant
of
Clostridium botulinum started to increase after 14 hours of culture and showed
a final
value of 31.41 ,ug/ml. When the toxin concentration was measured after
rupturing the
bacterium, the toxin started to be produced after 5 hours of culture, and the
toxin con-
centration continued to increase, was maintained at a uniform level after 28
hours of
culture, and showed a final value of 38.39 ,ug/ml.
[184] In conclusion, the finally selected APF (animal protein-free medium)
composition
determined based on the results of Examples 1 to 10 is summerized in Table 13.
[185]
24
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[186] [Table 131
Components of Medium g/L
Carbon Source Glucose 10
Nitrogen Hy-PeaTM 7404 5
Source UltraPepTM Cotton 10
(Vegetable
HyPepTm 4601N 5
Peptone)
KIHPO4 5.5
Mineral
Na,HPO4 3
[187]
[188] Example 11: Selection of Medium Composition Containing Plant-derived
Peptones
and Casein Hydrolysate
[189] The APF medium composition determined based on the results of
Examples 1 to 10
showed an increased growth rate of the bacterium compared to the medium that
is in
current use (original medium), but the addition of a medium component that
further
increases the growth rate of the bacterium while having no risk of infection
with TSE
or the like was taken into consideration. As a result, a TSE-free casein
hydrolysate
(e.g., TSE-certificated casein hydrolysate) was added to the APF medium, and
the
growth of the bacterium in the medium was examined.
[190] One or two TSE-free casein hydrolysates were added to the APF medium
determined
based on the results of Examples 1 to 10. Specifically, Clostridium botulinum
was
cultured in medium A (obtained by adding the casein hydrolysate N-Z-Amine A to
the
medium composition containing the plant-derived peptones), or medium B
(obtained
by adding N-Z-Case TT to the medium composition), or medium C (obtained by
adding casamino acid to the medium composition), or medium D (obtained by
adding
tryptone to the medium composition) for 24 hours and 48 hours, and the growth
of the
bacterium was examined by measuring the OD (540nm, 600nm) values during the
culture (Table 14). In addition, the results of the measurement were subjected
to sta-
tistical analysis using statistical program, thereby selecting a medium
composition
showing the highest growth at 24 hours of culture of the bacterium.
[191]
[192] Table 14 shows the results of the time-dependent growth of
Clostridium botulinum in
the medium compositions containing the casein hydrolysates in addition to the
plant-
25
CA 02968044 2017-05-16
WO 2016/175566
PCT/KR2016/004431
derived peptones.
[193]
[194] [Table 141
A B C D OD at 24hr OD at
48hr
StdOrder RunOrder
(N-Z-AMINE A) (N-Z-CASE TT) (Casamino acid) (Tryptone) 540nm , 600nm
540nm 600nm
1 11 2 0 0 0
4.7040 4.0620 2.3385 2.0715
2 . 6 0 2 0 0 4.8460 .
4.1540 1.2785 1.1525
3 _ 2 _ 0 0 2_ 0 ,
4.7470 , 4.1140 L7340 , 1.5510
_
4 10 0 0 0 2 4.5240 .
3.8620 1.1890 1.0710
4 1 1 0 0 5.1810 . 4.4540 1.5360
1.3720
6 3 1 0 1 0 4.9620 .
4.2900 2.0780 1.8460
7 , 13 1 0 0 1 4.7280 .
4.0700 1.2785 1.1475
8 9 0 1 1 0 4.8410 .
4.1700 1.5390 1.3735
9 7 0 1 0 1 4.8060 .
4.1370 L2260 1.1075
15 0 0 1 1 4.5690 . 3.9220 1.3800
1.2375
'
11 1 0.666666667 0.666666667 0.666666667 0
5.3350 . 4.5990 1.5385 1.3880
12 . 14 0.666666667 0.666666667 0 ,
0.666666667 4.9790 . 4.2880 1.3570 , 1.2035
13 . 5 0.666666667 0 0.666666667 0.666666667
4 9020 . 4.2160 1 7280 1 5575
14 8 00.666666667 0.666666667 0.666666667 4.9930
4.2820 1.5305 1.3670 _,
-
._ - - _.
12 0.5 0.5 0.5 0.5 4.8500 4.1860 1.4845 1.3250
[195]
[196] Meanwhile, as shown in FIG. 11, in order to find conditions showing
the highest
growth at 24 hours of culture of the bacterium, mixture contour plots for
lower bound
setting and middle setting conditions were drawn. As a result, it could be
seen that
Clostridium botulinum showed the highest growth in the region in which medium
A
and medium B exist and medium C and medium D show a value of 0. In addition,
as
shown in FIG. 12, conditions showing the highest growth of the bacterium were
in-
vestigated, and as a result, it was shown that the bacterium showed the
highest growth
under the following conditions: A=0.8725, B=1.1275, C=0, and D=0. Based on
such
results, medium A (N-Z-Amine A) and medium B (N-Z-Case TT) were finally
selected
from among the four medium components.
[197]
[198] Example 12: Final Selection of Concentration of Medium Containing
Plant-derived
Peptones and Casein Hydrolysate
[199] To determine optimal medium composition for the two casein
hydrolysate medium
components selected in Example 11, a response surface experiment was performed
with a CCF (central composite faced) design.
[200]
[201] Table 15 shows the results of analyzing the time-dependent growth of
Clostridium
botulinum in the medium composition containing the plant-derived peptones and
the
casein hydrolysates using the CCF response surface methodology.
[202]
26
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[203] [Table 151
A B OD at 24hr OD at 48hr
StdOrder RunOrder
(N-Z.-AMINE A) (N-Z-CASE TT) 540nrn 600nrn 540nrn 600nm
1 3 0 0 34850
2.9430 1.4095 1.2110
2 2 2 0
5.1410 4.4030 2.3800 2.0880
3 8 0 2
5.1410 4.4020 1.3590 1.1415
4 7 2 2 52690
4.5560 1.7715 1.5420
11 0 1 42000 3.5680 0.6885
0.6075
_
6 10 2 1
5.3730 4.6280 1.7055 1.4930
7 5 1 0
3.9240 3.3190 3.2370 2.8775
8 13 1 2
5.1380 4.4140 12905 1.1330
9 12 , 1 1
5.1850 4.4520 1.5585 1.3380
6 , 1 1 5.3810 4.6390 2.9825
2.6300
11 9 1 1 4.9080 , 4.2150
0.8165 0.7125
12 1 1 1
5.1150 4.3910 1.4515 1.2725
13 4 1 1 52110
4.4710 2.6785 2.3405
[204]
[205] As a result, as shown in Table 15, it was found that Clostridium
botulinum grew.
[206] Meanwhile, a contour plot of a model set using statistical
program was drawn. As
shown in FIG. 13 (A), the medium component A increased outside the
experimental
range, indicating that there are optimal conditions. To confirm it, the range
of the
medium component A (N-Z-Amine A) was extended outside the experimental range
using statistical program, and a contour plot was drawn. As a result, as shown
in FIG.
13(B), the growth of the bacterium increased as the concentration of the
medium
component A increased. However, because an increase in the content of the
casein hy-
drolysate can cause a problem in terms of solubility, an optimal condition was
selected
within the experimental ranges.
[207] As a result, the bacterium showed the highest growth at 24 hours of
culture under the
following conditions: A=2.0, and B=1.1402. Based on such results, a medium com-
position containing the casein hydrolysate added to the animal protein-free
(APF)
medium, which shows the highest growth of Clostridium botulinum, was
determined as
shown in Table 16.
[208]
27
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[209] [Table 161
Components of Medium g/L
Carbon Source Glucose 10
Nitrogen Source Hy-PeaTM 7404 5
(Vegetable UlfraPepTM Cotton 10
Pepton) HyPepTM 4601N 5
K,HPO, 5.5
Mineral
3
Nitrogen Source N-Z-AMINE A 20
(Ca sein
N-Z-CASE TT 11
Hy drolysate)
[210]
[211] Example 13: Growth Pattern of Clostridium botulinum in Medium
Containing Plant-
derived Peptones and Casein Hydrolysates
[212] Using the medium composition containing plant-derived peptones and/or
casein hy-
drolysates, determined based on the results of Examples 1 to 10, Clostridium
botulinum was cultured, and the growth pattern of the bacterium was examined.
[213] Table 17 shows time-dependent OD values of the growth of Clostridium
botulinum
between a medium that is in current use, a plant-derived peptone-containing
medium
(APF medium), and a final medium containing plant-derived peptones and casein
hy-
drolysates (APF medium + casein).
[214]
28
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
[215] [Table 171
medium that is in
current use APF Medium APF Medium+ Casein
Time of Culture(
540nm 600nm 540nm 600nm 540nm 600nm
hr) = =
0 0 0 0 0 0 0
10 0 0 0 0 0 0
12 0 0 0 0 0 0
15 0.0084 0.0059 0.2064 0.1821 0.7156 0.6551
18 0.073 0.0608 1.0552 0.9296 2.8395 2.5015
21 0.4952 0.4204 1.85 1.5895 4.545 3.92
24 1.2382 0.9954 2.8595 2.472 5.244 4.551
26 2.608 2.215 3.4745 3.009 5.628 4.786
28 2.8335 2.416 3.526 2.994 5.188 4.489
36 3.324 2.838 3.361 2.911 3.838 3.396
39 3.384 1.894 1.9155 1.5185 3.7115 3.2945
44 3.1105 2.6415 1.968 1.-12 2.9725 2.778
=
60 2.1484 1.8164 0.76 0.684 1.9788 1.7564
[216]
[217] As a result, as shown in Table 17 and FIG. 15, the medium that is in
current use
showed an increase in the growth rate after 24 hours of culture of Clostridium
botulinum and showed the peak 0D540. value of 3.384 at 39 hours of culture.
The APF
medium containing plant-derived peptones showed an increase in the growth rate
after
18 hours of culture and showed a peak 0D540. value of 3.526 at 28 hours of
culture.
[218] In addition, the plant-derived peptone-containing APF medium + casein
hydrolysate
showed an increase in the growth rate after 18 hours of culture and showed a
peak OD
540nm value of 5.628 at 26 hours of culture. When the 0D540nm value at 24
hours of
culture was compared, the medium that is in current use showed an 0D540nm
value of
1.2382, the plant-derived peptone-containing APF medium showed an 0D540. value
of
2.8595, and the plant-derived peptone-containing APF medium + casein
hydrolysate
showed an 0D540nm value of 5.244. Thus, the OD value of the plant-derived
peptone-
containing APF medium + casein hydrolysate at 24 hours of culture was about
4.23
times higher than that of the medium that is in current use and about 1.83
times higher
than that of the plant-derived peptone-containing APF medium. Moreover, the
peak
OD value of the plant-derived peptone-containing APF medium + casein
hydrolysate
was about 1.6 times higher than that of the plant-derived peptone-containing
APF
medium.
[219]
29
CA 02968044 2017-05-16
WO 2016/175566 PCT/KR2016/004431
Industrial Applicability
[220] As described above, when the medium according to the present
invention, which
contains plant-derived peptone, casein hydrolysate and mineral, is used for
culture of
Clostridium botulinum, the growth rate of the bacterium in the medium is
higher than
that in each of the medium that is in current use and the medium containing
plant-
derived peptone alone. In addition, when the medium of the present invention
is used,
a high concentration of botulinum toxin can be produced by culturing the
bacterium in
a safe manner.
[221]
[222] Although the present invention has been described in detail with
reference to the
specific features, it will be apparent to those skilled in the art that this
description is
only for a preferred embodiment and does not limit the scope of the present
invention.
Thus, the substantial scope of the present invention will be defined by the
appended
claims and equivalents thereof.
[223]
